Novacyt has made a move for the private sector with regards to COVID-19 testing as it announced the launch of mobile process laboratories.
These laboratories are designed to produce rapid turnaround of PCR tests on-site, with each processing unit capable of handling up to 900 COVID-19 tests per day.
The diagnostics specialist revealed that it is hopeful that this method of testing will be able to support on-site testing in environments such as sports, schools and workplaces and even music events.
Commenting on the move was CEO Graham Mullis who outlined this is a growth opportunity for the business:
“We believe this option provides companies and communities with reliable and fast turnaround results to deal with localised surge infections or for routine localised mass testing. The need for localised community testing and monitoring of COVID-19 infections looks set to continue over the next 12 months and it is our view that much of this testing could be undertaken by the private sector. Novacyt is therefore well-placed to support this growth opportunity.”
The Novacyt share price is currently trading at 692p.